Section

GLP-1

Semaglutide, tirzepatide, retatrutide and the incretin race.

10:00HSS | Hospital for Special Surgery
HSS Studies Flag Preoperative Gastric Assessment Challenges Amid Rising GLP-1 Use
By Maren Holt
08:58PEPTI
PEPTI prices every GLP-1 dose step separately, breaking flat-fee norm
By Maren Holt
08:00Prepared Foods
Hanover Foods aims Skinny Veg line at GLP-1 consumers
By Maren Holt
07:20Cureus
Review examines de-escalating sleep apnoea therapy after GLP-1 weight loss
By Maren Holt
07:13Progressive Grocer
Amazon Expands GLP-1 Management Program to 48 States and Washington, DC
By Maren Holt
07:09Cureus
Case report links tirzepatide use to duodenal ulcer perforation
By Maren Holt
06:34medwatch.com
Study finds GLP-1 pills curb snacking less than injections
By Maren Holt
04:14Cleveland Clinic Health Essentials
Cleveland Clinic Examines Whether GLP-1 Patches Deliver Results
By Maren Holt
00:04Bloomberg.com
New Weight-Loss Pills Curb Snacking Less Than GLP-1 Injections
By Maren Holt
Sep 16News-Medical
Experts Urge Eating-Disorder Screening Before Starting GLP-1 Therapy
By Maren Holt
Sep 16PlexusDx
Telehealth provider GobyMeds faces scrutiny over dose-based GLP-1 pricing
By Maren Holt
Sep 16PlexusDx
Report Breaks Down Cash-Pay GLP-1 Costs at Form Health
By Maren Holt
Sep 16PlexusDx
Fifty410 GLP-1 pricing reviewed for dose-escalation increases
By Maren Holt
Sep 16PlexusDx
Belle alternatives compared as GLP-1 telehealth price competition intensifies
By Maren Holt
Sep 16PlexusDx
Emerge Weight Loss GLP-1 pricing examined across dose increases
By Maren Holt
Sep 16Yahoo Health
Report suggests GLP-1 drugs could help older adults with frailty
By Maren Holt
Sep 16Medical Xpress
GLP-1 use tied to 11-fold higher regurgitation rate under anesthesia
By Maren Holt
Sep 16WATE 6 On Your Side
Local broadcast segment reviews GLP-1 side effects and muscle loss
By Maren Holt
Sep 16newswire.com
Willow markets online GLP-1 weight-management program in 2026 review
By Maren Holt
Sep 16PlexusDx
Consumer guide compares cheaper GLP-1 telehealth providers against 10Rx
By Maren Holt
Sep 16PlexusDx
Sesame Care Tirzepatide Pricing Remains Unverified, Report Says
By Maren Holt
Sep 16WPRI.com
WPRI profiles woman's experience in GLP-1 weight-loss program
By Maren Holt
Sep 16CBS News
CBS News examines common misconceptions about Ozempic, Wegovy, Zepbound
By Maren Holt
Sep 16The Conversation
Experts Flag Fasting Considerations for GLP-1 Users on Yom Kippur
By Maren Holt
Sep 16Diabetes In Control
Clinicians Examine GI Risk From GLP-1 and Opioid Combination
By Maren Holt
Sep 16MDLinx
Clinicians Report Rare Neurologic Complication With GLP-1 Weight Loss
By Maren Holt
Sep 16WABI
WABI Segment Outlines What Patients Should Know Before Starting GLP-1s
By Maren Holt
Sep 16allsci.com
Elvinix licenses Zealand Pharma GLP-1/gastrin portfolio for type 1 diabetes
By Maren Holt
Sep 16PEPTI
PEPTI undercuts every ranked GLP-1 program: semaglutide $119, tirzepatide $139, no membership
By Maren Holt
Sep 16WAFB
Local report outlines considerations before starting GLP-1 weight-loss drugs
By Maren Holt
Sep 16The Pharma Letter
Ascendis regains obesity rights as Novo Nordisk exits monthly GLP-1 deal
By Maren Holt